Novartis | NOVN - Aset Lancar

Harga Saham
115.60
Perubahan Harian
-1.28 -1.10%
Bulanan
-9.67%
Tahunan
16.50%
Q1 Perkiraan
118.31




Aset Lancar Perubahan Tanggal
AbbVie USD 29.06B 523M 2025-12
Alcon AG USD 6.45B 116M 2025-12
Almirall EUR 713.98M 69K 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Autolus Therapeutics Ltd USD 514.58M 59.67M 2025-09
Bayer EUR 32.91B 30M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Fresenius EUR 12.06B 1.18B 2025-09
Fresenius Medical Care EUR 7.9B 74M 2025-12
Galapagos EUR 3.08B 82.56M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
GRIFOLS EUR 5.07B 274.77M 2025-12
Hikma Pharmaceutical USD 2.64B 86M 2025-12
J&J USD 55.62B 1.01B 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.23B 354M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Orion EUR 1.34B 247.2M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Philips EUR 9.93B 654M 2025-12
Recordati EUR 1.71B 144.32M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
UCB EUR 6.05B 733M 2025-12